カテゴリー： LP Information, 世界, 医療/バイオ

世界の減量治療薬市場予測 2021年-2026年

【英語タイトル】Global Weight Loss Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9691）・商品コード：LPI21MY9691
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：166
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「減量治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、液体、錠剤など、用途別には、軽量化補助、その他などにセグメント区分してまとめました。減量治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・減量治療薬の世界市場概要（サマリー）
・減量治療薬の企業別販売量・売上
・減量治療薬の企業別市場シェア
・減量治療薬の世界市場規模 2016年-2021年：種類別（液体、錠剤）
・減量治療薬の世界市場規模 2016年-2021年：用途別（軽量化補助、その他）
・減量治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・減量治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・減量治療薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・減量治療薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・減量治療薬市場の成長要因・課題・動向
・減量治療薬の世界市場予測 2021年-2026年
・減量治療薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・減量治療薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・減量治療薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・減量治療薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・減量治療薬の世界市場予測：種類別（液体、錠剤）
・減量治療薬の世界市場予測：用途別（軽量化補助、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Weight Loss Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Weight Loss Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Liauid
Tablets

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Weight-reducing Aid
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Zein Pharmaceutical
Hisun
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
Dm Pharma
China Zhongshan Pharm

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Weight Loss Drugs Consumption 2016-2026
2.1.2 Weight Loss Drugs Consumption CAGR by Region
2.2 Weight Loss Drugs Segment by Type
2.2.1 Liauid
2.2.2 Tablets
2.3 Weight Loss Drugs Sales by Type
2.3.1 Global Weight Loss Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Weight Loss Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Weight Loss Drugs Sale Price by Type (2016-2021)
2.4 Weight Loss Drugs Segment by Application
2.4.1 Weight-reducing Aid
2.4.2 Other
2.5 Weight Loss Drugs Sales by Application
2.5.1 Global Weight Loss Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Weight Loss Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Weight Loss Drugs Sale Price by Application (2016-2021)

3 Global Weight Loss Drugs by Company
3.1 Global Weight Loss Drugs Sales Market Share by Company
3.1.1 Global Weight Loss Drugs Sales by Company (2019-2021)
3.1.2 Global Weight Loss Drugs Sales Market Share by Company (2019-2021)
3.2 Global Weight Loss Drugs Revenue Market Share by Company
3.2.1 Global Weight Loss Drugs Revenue by Company (2019-2021)
3.2.2 Global Weight Loss Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Weight Loss Drugs Sale Price by Company
3.4 Global Manufacturers Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Weight Loss Drugs Product Location Distribution
3.4.2 Players Weight Loss Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Weight Loss Drugs by Region
4.1 Global Weight Loss Drugs by Region
4.1.1 Global Weight Loss Drugs Sales by Region
4.1.2 Global Weight Loss Drugs Revenue by Region
4.2 Americas Weight Loss Drugs Sales Growth
4.3 APAC Weight Loss Drugs Sales Growth
4.4 Europe Weight Loss Drugs Sales Growth
4.5 Middle East & Africa Weight Loss Drugs Sales Growth

5 Americas
5.1 Americas Weight Loss Drugs Sales by Country
5.1.1 Americas Weight Loss Drugs Sales by Country (2016-2021)
5.1.2 Americas Weight Loss Drugs Revenue by Country (2016-2021)
5.2 Americas Weight Loss Drugs Sales by Type
5.3 Americas Weight Loss Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Weight Loss Drugs Sales by Region
6.1.1 APAC Weight Loss Drugs Sales by Region (2016-2021)
6.1.2 APAC Weight Loss Drugs Revenue by Region (2016-2021)
6.2 APAC Weight Loss Drugs Sales by Type
6.3 APAC Weight Loss Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Weight Loss Drugs by Country
7.1.1 Europe Weight Loss Drugs Sales by Country (2016-2021)
7.1.2 Europe Weight Loss Drugs Revenue by Country (2016-2021)
7.2 Europe Weight Loss Drugs Sales by Type
7.3 Europe Weight Loss Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Weight Loss Drugs by Country
8.1.1 Middle East & Africa Weight Loss Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Weight Loss Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Weight Loss Drugs Sales by Type
8.3 Middle East & Africa Weight Loss Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Weight Loss Drugs Distributors
10.3 Weight Loss Drugs Customer

11 Global Weight Loss Drugs Market Forecast
11.1 Global Weight Loss Drugs Forecast by Region
11.1.1 Global Weight Loss Drugs Forecast by Regions (2021-2026)
11.2.2 Global Weight Loss Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Weight Loss Drugs Forecast by Type
11.7 Global Weight Loss Drugs Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Roche Roche Company Information
12.1.2 Roche Weight Loss Drugs Product Offered
12.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Roche Main Business Overview
12.1.5 Roche Latest Developments
12.2 GSK group
12.2.1 GSK group Company Information
12.2.2 GSK group Weight Loss Drugs Product Offered
12.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK group Main Business Overview
12.2.5 GSK group Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Weight Loss Drugs Product Offered
12.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Sandoz(Novartis)
12.4.1 Sandoz(Novartis) Company Information
12.4.2 Sandoz(Novartis) Weight Loss Drugs Product Offered
12.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sandoz(Novartis) Main Business Overview
12.4.5 Sandoz(Novartis) Latest Developments
12.5 STADA-VN J.V.Co., Ltd
12.5.1 STADA-VN J.V.Co., Ltd Company Information
12.5.2 STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Offered
12.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 STADA-VN J.V.Co., Ltd Main Business Overview
12.5.5 STADA-VN J.V.Co., Ltd Latest Developments
12.6 Hexal AG
12.6.1 Hexal AG Company Information
12.6.2 Hexal AG Weight Loss Drugs Product Offered
12.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Hexal AG Main Business Overview
12.6.5 Hexal AG Latest Developments
12.7 National Company For Pharmaceutical Industry
12.7.1 National Company For Pharmaceutical Industry Company Information
12.7.2 National Company For Pharmaceutical Industry Weight Loss Drugs Product Offered
12.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 National Company For Pharmaceutical Industry Main Business Overview
12.7.5 National Company For Pharmaceutical Industry Latest Developments
12.8 Lunan Pharmaceutical Group Corporation
12.8.1 Lunan Pharmaceutical Group Corporation Company Information
12.8.2 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Offered
12.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Lunan Pharmaceutical Group Corporation Main Business Overview
12.8.5 Lunan Pharmaceutical Group Corporation Latest Developments
12.9 Zein Pharmaceutical
12.9.1 Zein Pharmaceutical Company Information
12.9.2 Zein Pharmaceutical Weight Loss Drugs Product Offered
12.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Zein Pharmaceutical Main Business Overview
12.9.5 Zein Pharmaceutical Latest Developments
12.10 Hisun
12.10.1 Hisun Company Information
12.10.2 Hisun Weight Loss Drugs Product Offered
12.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hisun Main Business Overview
12.10.5 Hisun Latest Developments
12.11 Taj Pharmaceuticals Ltd
12.11.1 Taj Pharmaceuticals Ltd Company Information
12.11.2 Taj Pharmaceuticals Ltd Weight Loss Drugs Product Offered
12.11.3 Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Taj Pharmaceuticals Ltd Main Business Overview
12.11.5 Taj Pharmaceuticals Ltd Latest Developments
12.12 Kabir Life Sciences & Research
12.12.1 Kabir Life Sciences & Research Company Information
12.12.2 Kabir Life Sciences & Research Weight Loss Drugs Product Offered
12.12.3 Kabir Life Sciences & Research Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Kabir Life Sciences & Research Main Business Overview
12.12.5 Kabir Life Sciences & Research Latest Developments
12.13 Dm Pharma
12.13.1 Dm Pharma Company Information
12.13.2 Dm Pharma Weight Loss Drugs Product Offered
12.13.3 Dm Pharma Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Dm Pharma Main Business Overview
12.13.5 Dm Pharma Latest Developments
12.14 China Zhongshan Pharm
12.14.1 China Zhongshan Pharm Company Information
12.14.2 China Zhongshan Pharm Weight Loss Drugs Product Offered
12.14.3 China Zhongshan Pharm Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 China Zhongshan Pharm Main Business Overview
12.14.5 China Zhongshan Pharm Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Weight Loss Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Liauid
Table 3. Major Players of Tablets
Table 4. Global Weight Loss Drugs Sales by Type (2016-2021) & (K Tablets)
Table 5. Global Weight Loss Drugs Sales Market Share by Type (2016-2021)
Table 6. Global Weight Loss Drugs Revenue by Type (2016-2021) & ($ million)
Table 7. Global Weight Loss Drugs Revenue Market Share by Type (2016-2021)
Table 8. Global Weight Loss Drugs Sale Price by Type (2016-2021)
Table 9. Global Weight Loss Drugs Sales by Application (2016-2021) & (K Tablets)
Table 10. Global Weight Loss Drugs Sales Market Share by Application (2016-2021)
Table 11. Global Weight Loss Drugs Value by Application (2016-2021)
Table 12. Global Weight Loss Drugs Revenue Market Share by Application (2016-2021)
Table 13. Global Weight Loss Drugs Sale Price by Application (2016-2021)
Table 14. Global Weight Loss Drugs Sales by Company (2019-2021) & (K Tablets)
Table 15. Global Weight Loss Drugs Sales Market Share by Company (2019-2021)
Table 16. Global Weight Loss Drugs Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Weight Loss Drugs Revenue Market Share by Company (2019-2021)
Table 18. Global Weight Loss Drugs Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Weight Loss Drugs Producing Area Distribution and Sales Area
Table 20. Players Weight Loss Drugs Products Offered
Table 21. Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Weight Loss Drugs Sales by Region (2016-2021) (K Tablets)
Table 25. Global Weight Loss Drugs Sales Market Share by Region (2016-2021)
Table 26. Global Weight Loss Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Weight Loss Drugs Revenue Market Share by Region (2016-2021)
Table 28. Americas Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 29. Americas Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 30. Americas Weight Loss Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 32. Americas Weight Loss Drugs Sales by Type (2016-2021) & (K Tablets)
Table 33. Americas Weight Loss Drugs Sales Market Share by Type (2016-2021)
Table 34. Americas Weight Loss Drugs Sales by Application (2016-2021) & (K Tablets)
Table 35. Americas Weight Loss Drugs Sales Market Share by Application (2016-2021)
Table 36. APAC Weight Loss Drugs Sales by Region (2016-2021) & (K Tablets)
Table 37. APAC Weight Loss Drugs Sales Market Share by Region (2016-2021)
Table 38. APAC Weight Loss Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Weight Loss Drugs Revenue Market Share by Region (2016-2021)
Table 40. APAC Weight Loss Drugs Sales by Type (2016-2021) & (K Tablets)
Table 41. APAC Weight Loss Drugs Sales Market Share by Type (2016-2021)
Table 42. APAC Weight Loss Drugs Sales by Application (2016-2021) & (K Tablets)
Table 43. APAC Weight Loss Drugs Sales Market Share by Application (2016-2021)
Table 44. Europe Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 45. Europe Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 46. Europe Weight Loss Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 48. Europe Weight Loss Drugs Sales by Type (2016-2021) & (K Tablets)
Table 49. Europe Weight Loss Drugs Sales Market Share by Type (2016-2021)
Table 50. Europe Weight Loss Drugs Sales by Application (2016-2021) & (K Tablets)
Table 51. Europe Weight Loss Drugs Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Weight Loss Drugs Sales by Country (2016-2021) & (K Tablets)
Table 53. Middle East & Africa Weight Loss Drugs Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Weight Loss Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Weight Loss Drugs Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Weight Loss Drugs Sales by Type (2016-2021) & (K Tablets)
Table 57. Middle East & Africa Weight Loss Drugs Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Weight Loss Drugs Sales by Application (2016-2021) & (K Tablets)
Table 59. Middle East & Africa Weight Loss Drugs Sales Market Share by Application (2016-2021)
Table 60. Global Weight Loss Drugs Sales Forecast by Type (2021-2026) & (K Tablets)
Table 61. Global Weight Loss Drugs Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Weight Loss Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Weight Loss Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Weight Loss Drugs Sales Forecast by Application (2021-2026) & (K Tablets)
Table 65. Global Weight Loss Drugs Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Weight Loss Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Weight Loss Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 68. Roche Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 69. Roche Weight Loss Drugs Product Offered
Table 70. Roche Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 71. Roche Main Business
Table 72. Roche Latest Developments
Table 73. GSK group Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. GSK group Weight Loss Drugs Product Offered
Table 75. GSK group Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 76. GSK group Main Business
Table 77. GSK group Latest Developments
Table 78. Teva Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Weight Loss Drugs Product Offered
Table 80. Teva Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 81. Teva Main Business
Table 82. Teva Latest Developments
Table 83. Sandoz(Novartis) Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Sandoz(Novartis) Weight Loss Drugs Product Offered
Table 85. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 86. Sandoz(Novartis) Main Business
Table 87. Sandoz(Novartis) Latest Developments
Table 88. STADA-VN J.V.Co., Ltd Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Offered
Table 90. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 91. STADA-VN J.V.Co., Ltd Main Business
Table 92. STADA-VN J.V.Co., Ltd Latest Developments
Table 93. Hexal AG Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Hexal AG Weight Loss Drugs Product Offered
Table 95. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 96. Hexal AG Main Business
Table 97. Hexal AG Latest Developments
Table 98. National Company For Pharmaceutical Industry Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. National Company For Pharmaceutical Industry Weight Loss Drugs Product Offered
Table 100. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 101. National Company For Pharmaceutical Industry Main Business
Table 102. National Company For Pharmaceutical Industry Latest Developments
Table 103. Lunan Pharmaceutical Group Corporation Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Offered
Table 105. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 106. Lunan Pharmaceutical Group Corporation Main Business
Table 107. Lunan Pharmaceutical Group Corporation Latest Developments
Table 108. Zein Pharmaceutical Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Zein Pharmaceutical Weight Loss Drugs Product Offered
Table 110. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 111. Zein Pharmaceutical Main Business
Table 112. Zein Pharmaceutical Latest Developments
Table 113. Hisun Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Hisun Weight Loss Drugs Product Offered
Table 115. Hisun Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 116. Hisun Main Business
Table 117. Hisun Latest Developments
Table 118. Taj Pharmaceuticals Ltd Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals Ltd Weight Loss Drugs Product Offered
Table 120. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 121. Taj Pharmaceuticals Ltd Main Business
Table 122. Taj Pharmaceuticals Ltd Latest Developments
Table 123. Kabir Life Sciences & Research Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Kabir Life Sciences & Research Weight Loss Drugs Product Offered
Table 125. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 126. Kabir Life Sciences & Research Main Business
Table 127. Kabir Life Sciences & Research Latest Developments
Table 128. Dm Pharma Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Dm Pharma Weight Loss Drugs Product Offered
Table 130. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 131. Dm Pharma Main Business
Table 132. Dm Pharma Latest Developments
Table 133. China Zhongshan Pharm Basic Information, Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. China Zhongshan Pharm Weight Loss Drugs Product Offered
Table 135. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue ($ Million), Price (USD/Tablet) and Gross Margin (2019-2021E)
Table 136. China Zhongshan Pharm Main Business
Table 137. China Zhongshan Pharm Latest Developments
List of Figures
Figure 1. Picture of Weight Loss Drugs
Figure 2. Weight Loss Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Weight Loss Drugs Sales Growth Rate 2016-2026 (K Tablets)
Figure 7. Global Weight Loss Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Weight Loss Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Liauid
Figure 10. Product Picture of Tablets
Figure 11. Global Weight Loss Drugs Sales Market Share by Type in 2020
Figure 12. Global Weight Loss Drugs Revenue Market Share by Type (2016-2021)
Figure 13. Weight Loss Drugs Consumed in Weight-reducing Aid
Figure 14. Global Weight Loss Drugs Market: Weight-reducing Aid (2016-2021) & (K Tablets)
Figure 15. Weight Loss Drugs Consumed in Other
Figure 16. Global Weight Loss Drugs Market: Other (2016-2021) & (K Tablets)
Figure 17. Global Weight Loss Drugs Sales Market Share by Application (2016-2021)
Figure 18. Global Weight Loss Drugs Revenue Market Share by Application in 2020
Figure 19. Global Weight Loss Drugs Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Weight Loss Drugs Revenue Market Share by Company in 2020
Figure 21. Global Weight Loss Drugs Sales Market Share by Regions (2016-2021)
Figure 22. Global Weight Loss Drugs Revenue Market Share by Region in 2020
Figure 23. Americas Weight Loss Drugs Sales 2016-2021 (K Tablets)
Figure 24. Americas Weight Loss Drugs Revenue 2016-2021 ($ Millions)
Figure 25. APAC Weight Loss Drugs Sales 2016-2021 (K Tablets)
Figure 26. APAC Weight Loss Drugs Revenue 2016-2021 ($ Millions)
Figure 27. Europe Weight Loss Drugs Sales 2016-2021 (K Tablets)
Figure 28. Europe Weight Loss Drugs Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Weight Loss Drugs Sales 2016-2021 (K Tablets)
Figure 30. Middle East & Africa Weight Loss Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Americas Weight Loss Drugs Sales Market Share by Country in 2020
Figure 32. Americas Weight Loss Drugs Revenue Market Share by Country in 2020
Figure 33. Americas Weight Loss Drugs Sales Market Share by Type in 2020
Figure 34. Americas Weight Loss Drugs Sales Market Share by Application in 2020
Figure 35. United States Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Weight Loss Drugs Sales Market Share by Region in 2020
Figure 40. APAC Weight Loss Drugs Revenue Market Share by Regions in 2020
Figure 41. APAC Weight Loss Drugs Sales Market Share by Type in 2020
Figure 42. APAC Weight Loss Drugs Sales Market Share by Application in 2020
Figure 43. China Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Weight Loss Drugs Sales Market Share by Country in 2020
Figure 50. Europe Weight Loss Drugs Revenue Market Share by Country in 2020
Figure 51. Europe Weight Loss Drugs Sales Market Share by Type in 2020
Figure 52. Europe Weight Loss Drugs Sales Market Share by Application in 2020
Figure 53. Germany Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Weight Loss Drugs Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Weight Loss Drugs Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Weight Loss Drugs Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Weight Loss Drugs Sales Market Share by Application in 2020
Figure 62. Egypt Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Weight Loss Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


★調査レポート[世界の減量治療薬市場予測 2021年-2026年] (コード：LPI21MY9691)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の減量治療薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の減量式フィーダー市場予測 2021年-2026年
    LPI21MY7269 / LP Information / 2021年5月 / LPインフォメーション社の「減量式フィーダーの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、シングルスクリューフィーダー、ツインスクリューフィーダー、その他など、用途別には、食品・飲料、鉱業・冶金、製薬、建設、プラスチック、化学薬品、その他などにセグメント区分してまとめました。減量式フィーダーのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・減量式フィーダーの世界市場概要（サマリー） ・減量式フィーダーの企業別販売量・売上 ・減量式フィーダーの企業別市場シェア ・減量式フィーダーの世界市場規模 2016年-2021年：種類別（シングルスクリューフィーダー、ツインスクリューフィーダー、その他） ・減量式フィーダーの世界市場規模 2016年-2021年：用途別（食品・飲料、鉱業・冶金、製薬、建設、プラスチック、化学薬品、その他） ・減量式フィーダーの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・減量式フィーダーのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Loss-in-weight Feeders will have significant change from previous year. By the most conservative estimates of global Loss-in-weight Feeders market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Loss-in-weight Feeders market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Loss-in-weight Feeders market by product type, application, key manufacturers and...
  • 世界の減量薬市場予測 2021年-2026年
    LPI21MY9693 / LP Information / 2021年5月 / LPインフォメーション社の「減量薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、液体、錠剤など、用途別には、軽量化補助、その他などにセグメント区分してまとめました。減量薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・減量薬の世界市場概要（サマリー） ・減量薬の企業別販売量・売上 ・減量薬の企業別市場シェア ・減量薬の世界市場規模 2016年-2021年：種類別（液体、錠剤） ・減量薬の世界市場規模 2016年-2021年：用途別（軽量化補助、その他） ・減量薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・減量薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Weight Reduction Medicine will have significant change from previous year. By the most conservative estimates of global Weight Reduction Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Weight Reduction Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Weight Reduction Medicine market by product type,...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...
  • 世界のCD38モノクローナル抗体薬市場予測 2021年-2026年
    LPI21MY9468 / LP Information / 2021年5月 / LPインフォメーション社の「CD38モノクローナル抗体薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ダレツズマブ、イサルツキシマブ、人工毒素体など、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他などにセグメント区分してまとめました。CD38モノクローナル抗体薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・CD38モノクローナル抗体薬の世界市場概要（サマリー） ・CD38モノクローナル抗体薬の企業別販売量・売上 ・CD38モノクローナル抗体薬の企業別市場シェア ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：種類別（ダレツズマブ、イサルツキシマブ、人工毒素体） ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：用途別（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他） ・CD38モノクローナル抗体薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・CD38モノクローナル抗体薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of CD38 Monoclonal Antibody Drugs will have significant change from previous year. By the most conservative estimates of global CD38 Monoclonal Antibody Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CD38 Monoclonal Antibody Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of CD38 Monoclonal Antibody Drugs...
  • 世界のオキシコドン塩酸塩治療薬市場予測 2021年-2026年
    LPI21MY9614 / LP Information / 2021年5月 / LPインフォメーション社の「オキシコドン塩酸塩治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤、経口カプセル、静脈内輸液など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。オキシコドン塩酸塩治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシコドン塩酸塩治療薬の世界市場概要（サマリー） ・オキシコドン塩酸塩治療薬の企業別販売量・売上 ・オキシコドン塩酸塩治療薬の企業別市場シェア ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：種類別（錠剤、経口液剤、経口カプセル、静脈内輸液） ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・オキシコドン塩酸塩治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシコドン塩酸塩治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Oxycodone Hydrochloride Drugs will have significant change from previous year. By the most conservative estimates of global Oxycodone Hydrochloride Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxycodone Hydrochloride Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Drugs market by product type,...
  • 世界のイマチニブ薬市場予測 2021年-2026年
    LPI21MY9644 / LP Information / 2021年5月 / LPインフォメーション社の「イマチニブ薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カプセル、錠剤など、用途別には、病院、ドラッグストア、その他などにセグメント区分してまとめました。イマチニブ薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イマチニブ薬の世界市場概要（サマリー） ・イマチニブ薬の企業別販売量・売上 ・イマチニブ薬の企業別市場シェア ・イマチニブ薬の世界市場規模 2016年-2021年：種類別（カプセル、錠剤） ・イマチニブ薬の世界市場規模 2016年-2021年：用途別（病院、ドラッグストア、その他） ・イマチニブ薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イマチニブ薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Imatinib Drugs will have significant change from previous year. By the most conservative estimates of global Imatinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Imatinib Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drugs market by product type, application, key manufacturers and...
  • 世界の抗消化性潰瘍薬市場予測 2021年-2026年
    LPI21MY9411 / LP Information / 2021年5月 / LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗消化性潰瘍薬の世界市場概要（サマリー） ・抗消化性潰瘍薬の企業別販売量・売上 ・抗消化性潰瘍薬の企業別市場シェア ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs...
  • 世界の口腔内潰瘍治療薬市場予測 2021年-2026年
    LPI21MY9594 / LP Information / 2021年5月 / LPインフォメーション社の「口腔内潰瘍治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、コルチコステロイド、麻酔薬、鎮痛薬、抗ヒスタミン薬、抗菌薬など、用途別には、口内炎、口腔扁平苔癬、その他などにセグメント区分してまとめました。口腔内潰瘍治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・口腔内潰瘍治療薬の世界市場概要（サマリー） ・口腔内潰瘍治療薬の企業別販売量・売上 ・口腔内潰瘍治療薬の企業別市場シェア ・口腔内潰瘍治療薬の世界市場規模 2016年-2021年：種類別（コルチコステロイド、麻酔薬、鎮痛薬、抗ヒスタミン薬、抗菌薬） ・口腔内潰瘍治療薬の世界市場規模 2016年-2021年：用途別（口内炎、口腔扁平苔癬、その他） ・口腔内潰瘍治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・口腔内潰瘍治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mouth Ulcers Drugs will have significant change from previous year. By the most conservative estimates of global Mouth Ulcers Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mouth Ulcers Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mouth Ulcers Drugs market by product type,...
  • 世界の降圧薬市場予測 2021年-2026年
    LPI21MY9420 / LP Information / 2021年5月 / LPインフォメーション社の「降圧薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。降圧薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・降圧薬の世界市場概要（サマリー） ・降圧薬の企業別販売量・売上 ・降圧薬の企業別市場シェア ・降圧薬の世界市場規模 2016年-2021年：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・降圧薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・降圧薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・降圧薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Hypertensive Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Hypertensive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 39390 million in 2019. Over the next five years the Anti-Hypertensive Drugs market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 42110 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Hypertensive Drugs market by product type, application, key manufacturers and...
  • 世界の光損失試験セット市場予測 2021年-2026年
    LPI21MY7546 / LP Information / 2021年5月 / LPインフォメーション社の「光損失試験セットの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、シンプルモード試験、マルチモード試験など、用途別には、ネットワーク試験、企業構造化ケーブル、光ファイバー検出、その他などにセグメント区分してまとめました。光損失試験セットのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・光損失試験セットの世界市場概要（サマリー） ・光損失試験セットの企業別販売量・売上 ・光損失試験セットの企業別市場シェア ・光損失試験セットの世界市場規模 2016年-2021年：種類別（シンプルモード試験、マルチモード試験） ・光損失試験セットの世界市場規模 2016年-2021年：用途別（ネットワーク試験、企業構造化ケーブル、光ファイバー検出、その他） ・光損失試験セットの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・光損失試験セットのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Optical Loss Test Set will have significant change from previous year. By the most conservative estimates of global Optical Loss Test Set market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Optical Loss Test Set market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Optical Loss Test Set...

    • ◆H&Iグローバルリサーチのお客様（例）◆